<h3>关键洞察</h3>
<ul>
<li>SCSK 的估计公允价值为 3828 日元，基于两阶段自由现金流折现法</li>
<li>SCSK 的股价为 4351 日元，表明其交易水平与公允价值估计相似</li>
<li>我们的公允价值估计比 SCSK 分析师的价格目标（4543 日元）低 16%</li>
</ul>
<p>今天我们将简单介绍一种估值方法，用于评估 SCSK Corporation (TSE:9719) 作为投资机会的吸引力，通过预测公司的未来现金流并将其折现回今天的价值。我们的分析将采用折现现金流（DCF）模型。不要被术语吓到，背后的数学其实相当简单。</p>
<p>我们要提醒的是，估值公司有很多方法，像 DCF 一样，每种技术在某些情况下都有其优缺点。如果你对这种估值方法还有一些疑问，可以查看 Simply Wall St 的分析模型。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<h2>计算</h2>
<p>我们将使用两阶段 DCF 模型，顾名思义，它考虑了两个阶段的增长。第一阶段通常是一个较高的增长期，随后趋于稳定，进入第二个 “稳定增长” 阶段。首先，我们需要估计未来十年的现金流。在可能的情况下，我们使用分析师的估计，但当这些不可用时，我们会从上一个估计或报告值中推算出之前的自由现金流（FCF）。我们假设自由现金流减少的公司将减缓其缩减速度，而自由现金流增长的公司在此期间将看到其增长率放缓。我们这样做是为了反映出早期的增长往往比后期放缓得更快。</p>
<p>通常我们假设今天的一美元比未来的一美元更有价值，因此这些未来现金流的总和将折现到今天的价值：</p>
<h4>10 年自由现金流（FCF）估计</h4>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td><strong>2026</strong></td>
<td><strong>2027</strong></td>
<td><strong>2028</strong></td>
<td><strong>2029</strong></td>
<td><strong>2030</strong></td>
<td><strong>2031</strong></td>
<td><strong>2032</strong></td>
<td><strong>2033</strong></td>
<td><strong>2034</strong></td>
<td><strong>2035</strong></td>
</tr>
<tr>
<td><strong>杠杆自由现金流（¥，百万）</strong></td>
<td>642 亿日元</td>
<td>717 亿日元</td>
<td>780 亿日元</td>
<td>771 亿日元</td>
<td>839 亿日元</td>
<td>867 亿日元</td>
<td>889 亿日元</td>
<td>905 亿日元</td>
<td>918 亿日元</td>
<td>929 亿日元</td>
</tr>
<tr>
<td><strong>增长率估计来源</strong></td>
<td>分析师 x4</td>
<td>分析师 x4</td>
<td>分析师 x4</td>
<td>分析师 x1</td>
<td>分析师 x1</td>
<td>估计 @3.36%</td>
<td>估计 @2.49%</td>
<td>估计 @1.87%</td>
<td>估计 @1.45%</td>
<td>估计 @1.15%</td>
</tr>
<tr>
<td><strong>现值（¥，百万）折现 @7.5%</strong></td>
<td>597 亿日元</td>
<td>620 亿日元</td>
<td>628 亿日元</td>
<td>577 亿日元</td>
<td>584 亿日元</td>
<td>562 亿日元</td>
<td>536 亿日元</td>
<td>508 亿日元</td>
<td>479 亿日元</td>
<td>451 亿日元</td>
</tr>
</tbody>
</table>
<p><em>(&#34;Est&#34; = FCF 增长率由 Simply Wall St 估计)</em></p>
<p><strong>10 年现金流现值（PVCF）</strong> = 5540 亿日元</p>
<p>第二阶段也称为终值，这是业务在第一阶段后的现金流。使用戈登增长公式计算终值，未来年增长率等于 10 年期政府债券收益率的 5 年平均值 0.4%。我们以 7.5% 的股本成本将终端现金流折现到今天的价值。</p>
<p><strong>终值（TV）</strong> = FCF2035 × (1 + g) ÷ (r – g) = 930 亿日元× (1 + 0.4%) ÷ (7.5%– 0.4%) = 1.3 万亿日元</p>
<p><strong>终值现值（PVTV）</strong> = TV / (1 + r) 10= 1.3 万亿日元÷ ( 1 + 7.5%) 10= 6420 亿日元</p>
<p>总价值是未来十年的现金流总和加上折现的终值，得出总股本价值，在这种情况下为 1.2 万亿日元。在最后一步中，我们将股本价值除以流通股数。相对于当前股价 4400 日元，该公司在撰写时似乎接近公允价值。任何计算中的假设对估值有很大影响，因此最好将其视为粗略估计，而不是精确到最后一分钱。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/881041-dcf-1-dark-2/1753846130099?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/881041-dcf-1-dark-2/1753846130099"/></p>
<p>TSE:9719 折现现金流 2025 年 7 月 30 日</p>
<h2>重要假设</h2>
<p>我们要指出，折现现金流中最重要的输入是折现率和实际现金流。你不必同意这些输入，我建议你自己重新计算并进行调整。DCF 也没有考虑行业的周期性或公司的未来资本需求，因此无法全面反映公司的潜在表现。鉴于我们将 SCSK 视为潜在股东，折现率使用股本成本，而不是资本成本（或加权平均资本成本，WACC），后者考虑了债务。在此计算中，我们使用了 7.5%，这是基于 1.338 的杠杆贝塔。贝塔是衡量股票相对于整个市场波动性的指标。我们从全球可比公司的行业平均贝塔中获得我们的贝塔，并设定在 0.8 到 2.0 之间，这是一个适合稳定企业的合理范围。</p>
<p>查看我们对 SCSK 的最新分析</p>
<h3>SCSK 的 SWOT 分析</h3>
<p><strong>优势</strong></p>
<ul>
<li>过去一年的盈利增长超过了其 5 年平均水平。</li>
</ul>
<ul>
<li>债务由盈利和现金流良好覆盖。</li>
</ul>
<ul>
<li>股息由盈利和现金流覆盖。</li>
</ul>
<p>9719 的股息信息。</p>
<p><strong>劣势</strong></p>
<ul>
<li>过去一年的盈利增长低于 IT 行业。</li>
</ul>
<ul>
<li>与 IT 市场前 25% 的股息支付者相比，股息较低。</li>
</ul>
<p><strong>机会</strong></p>
<ul>
<li>年度盈利预计将比日本市场增长更快。</li>
</ul>
<ul>
<li>基于市盈率的估值相对公允市盈率而言具有良好价值。</li>
</ul>
<p><strong>威胁</strong></p>
<ul>
<li>收入预计每年增长低于 20%。</li>
</ul>
<p>分析师对 9719 还有什么其他预测？</p>
<h2>展望未来：</h2>
<p>估值只是构建投资论点的一个方面，它只是你需要评估公司的众多因素之一。使用折现现金流（DCF）模型无法获得万无一失的估值。最好是应用不同的情景和假设，看看它们如何影响公司的估值。例如，如果终值增长率稍作调整，整体结果可能会发生显著变化。对于 SCSK，还有三个进一步的事项你应该探索：</p>
<ol>
<li><strong>风险</strong>：例如，我们已经识别出 <strong>SCSK 的一个警示信号</strong>，你应该注意。</li>
<li><strong>未来收益</strong>：9719 的增长率与其同行和更广泛市场相比如何？通过与我们的免费分析师增长预期图表互动，深入挖掘未来几年的分析师共识数字。</li>
<li><strong>其他高质量替代品</strong>：你喜欢全能型股票吗？探索我们互动式的高质量股票列表，了解你可能错过的其他投资机会！</li>
</ol>
<p>PS. Simply Wall St 每天都会更新每只日本股票的 DCF 计算，因此如果你想找到其他股票的内在价值，只需在这里搜索。</p>

9719

<p>SCSK Corporation（东京证券交易所代码：9719）的估计公允价值为 3,828 日元，目前股价为 4,351 日元，表明其交易接近公允价值。该估计比分析师的目标价 4,543 日元低 16%。该估值是使用两阶段折现现金流（DCF）模型进行的，该模型考虑了未来现金流并将其折现为现值。计算出的总股权价值为 1.2 万亿日元，表明该公司目前大致处于公允价值</p>

<h3>Key Insights</h3>
<div class="lb-trans"><h3>关键洞察</h3>
</div><ul>
<li>SCSK's estimated fair value is JP¥3,828 based on 2 Stage Free Cash Flow to Equity</li>
<li>SCSK's JP¥4,351 share price indicates it is trading at similar levels as its fair value estimate</li>
<li>Our fair value estimate is 16% lower than SCSK's analyst price target of JP¥4,543</li>
</ul>
<div class="lb-trans"><ul>
<li>SCSK 的估计公允价值为 3828 日元，基于两阶段自由现金流折现法</li>
<li>SCSK 的股价为 4351 日元，表明其交易水平与公允价值估计相似</li>
<li>我们的公允价值估计比 SCSK 分析师的价格目标（4543 日元）低 16%</li>
</ul>
</div><p>Today we'll do a simple run through of a valuation method used to estimate the attractiveness of SCSK Corporation (TSE:9719) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.</p>
<div class="lb-trans"><p>今天我们将简单介绍一种估值方法，用于评估 SCSK Corporation (TSE:9719) 作为投资机会的吸引力，通过预测公司的未来现金流并将其折现回今天的价值。我们的分析将采用折现现金流（DCF）模型。不要被术语吓到，背后的数学其实相当简单。</p>
</div><p>We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.</p>
<div class="lb-trans"><p>我们要提醒的是，估值公司有很多方法，像 DCF 一样，每种技术在某些情况下都有其优缺点。如果你对这种估值方法还有一些疑问，可以查看 Simply Wall St 的分析模型。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><h2>The Calculation</h2>
<div class="lb-trans"><h2>计算</h2>
</div><p>We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.</p>
<div class="lb-trans"><p>我们将使用两阶段 DCF 模型，顾名思义，它考虑了两个阶段的增长。第一阶段通常是一个较高的增长期，随后趋于稳定，进入第二个 “稳定增长” 阶段。首先，我们需要估计未来十年的现金流。在可能的情况下，我们使用分析师的估计，但当这些不可用时，我们会从上一个估计或报告值中推算出之前的自由现金流（FCF）。我们假设自由现金流减少的公司将减缓其缩减速度，而自由现金流增长的公司在此期间将看到其增长率放缓。我们这样做是为了反映出早期的增长往往比后期放缓得更快。</p>
</div><p>Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value:</p>
<div class="lb-trans"><p>通常我们假设今天的一美元比未来的一美元更有价值，因此这些未来现金流的总和将折现到今天的价值：</p>
</div><h4>10-year free cash flow (FCF) estimate</h4>
<div class="lb-trans"><h4>10 年自由现金流（FCF）估计</h4>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td><strong>2026</strong></td>
<td><strong>2027</strong></td>
<td><strong>2028</strong></td>
<td><strong>2029</strong></td>
<td><strong>2030</strong></td>
<td><strong>2031</strong></td>
<td><strong>2032</strong></td>
<td><strong>2033</strong></td>
<td><strong>2034</strong></td>
<td><strong>2035</strong></td>
</tr>
<tr>
<td><strong>Levered FCF (¥, Millions)</strong></td>
<td>JP¥64.2b</td>
<td>JP¥71.7b</td>
<td>JP¥78.0b</td>
<td>JP¥77.1b</td>
<td>JP¥83.9b</td>
<td>JP¥86.7b</td>
<td>JP¥88.9b</td>
<td>JP¥90.5b</td>
<td>JP¥91.8b</td>
<td>JP¥92.9b</td>
</tr>
<tr>
<td><strong>Growth Rate Estimate Source</strong></td>
<td>Analyst x4</td>
<td>Analyst x4</td>
<td>Analyst x4</td>
<td>Analyst x1</td>
<td>Analyst x1</td>
<td>Est @ 3.36%</td>
<td>Est @ 2.49%</td>
<td>Est @ 1.87%</td>
<td>Est @ 1.45%</td>
<td>Est @ 1.15%</td>
</tr>
<tr>
<td><strong>Present Value (¥, Millions) Discounted @ 7.5%</strong></td>
<td>JP¥59.7k</td>
<td>JP¥62.0k</td>
<td>JP¥62.8k</td>
<td>JP¥57.7k</td>
<td>JP¥58.4k</td>
<td>JP¥56.2k</td>
<td>JP¥53.6k</td>
<td>JP¥50.8k</td>
<td>JP¥47.9k</td>
<td>JP¥45.1k</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td><strong>2026</strong></td>
<td><strong>2027</strong></td>
<td><strong>2028</strong></td>
<td><strong>2029</strong></td>
<td><strong>2030</strong></td>
<td><strong>2031</strong></td>
<td><strong>2032</strong></td>
<td><strong>2033</strong></td>
<td><strong>2034</strong></td>
<td><strong>2035</strong></td>
</tr>
<tr>
<td><strong>杠杆自由现金流（¥，百万）</strong></td>
<td>642 亿日元</td>
<td>717 亿日元</td>
<td>780 亿日元</td>
<td>771 亿日元</td>
<td>839 亿日元</td>
<td>867 亿日元</td>
<td>889 亿日元</td>
<td>905 亿日元</td>
<td>918 亿日元</td>
<td>929 亿日元</td>
</tr>
<tr>
<td><strong>增长率估计来源</strong></td>
<td>分析师 x4</td>
<td>分析师 x4</td>
<td>分析师 x4</td>
<td>分析师 x1</td>
<td>分析师 x1</td>
<td>估计 @3.36%</td>
<td>估计 @2.49%</td>
<td>估计 @1.87%</td>
<td>估计 @1.45%</td>
<td>估计 @1.15%</td>
</tr>
<tr>
<td><strong>现值（¥，百万）折现 @7.5%</strong></td>
<td>597 亿日元</td>
<td>620 亿日元</td>
<td>628 亿日元</td>
<td>577 亿日元</td>
<td>584 亿日元</td>
<td>562 亿日元</td>
<td>536 亿日元</td>
<td>508 亿日元</td>
<td>479 亿日元</td>
<td>451 亿日元</td>
</tr>
</tbody>
</table>
</div><p><em>(&#34;Est&#34; = FCF growth rate estimated by Simply Wall St)</em></p>
<div class="lb-trans"><p><em>(&#34;Est&#34; = FCF 增长率由 Simply Wall St 估计)</em></p>
</div><p><strong>Present Value of 10-year Cash Flow (PVCF)</strong> = JP¥554b</p>
<div class="lb-trans"><p><strong>10 年现金流现值（PVCF）</strong> = 5540 亿日元</p>
</div><p>The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.4%. We discount the terminal cash flows to today's value at a cost of equity of 7.5%.</p>
<div class="lb-trans"><p>第二阶段也称为终值，这是业务在第一阶段后的现金流。使用戈登增长公式计算终值，未来年增长率等于 10 年期政府债券收益率的 5 年平均值 0.4%。我们以 7.5% 的股本成本将终端现金流折现到今天的价值。</p>
</div><p><strong>Terminal Value (TV)</strong> = FCF2035 × (1 + g) ÷ (r – g) = JP¥93b× (1 + 0.4%) ÷ (7.5%– 0.4%) = JP¥1.3t</p>
<div class="lb-trans"><p><strong>终值（TV）</strong> = FCF2035 × (1 + g) ÷ (r – g) = 930 亿日元× (1 + 0.4%) ÷ (7.5%– 0.4%) = 1.3 万亿日元</p>
</div><p><strong>Present Value of Terminal Value (PVTV)</strong> = TV / (1 + r) 10= JP¥1.3t÷ ( 1 + 7.5%) 10= JP¥642b</p>
<div class="lb-trans"><p><strong>终值现值（PVTV）</strong> = TV / (1 + r) 10= 1.3 万亿日元÷ ( 1 + 7.5%) 10= 6420 亿日元</p>
</div><p>The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is JP¥1.2t. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of JP¥4.4k, the company appears around fair value at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.</p>
<div class="lb-trans"><p>总价值是未来十年的现金流总和加上折现的终值，得出总股本价值，在这种情况下为 1.2 万亿日元。在最后一步中，我们将股本价值除以流通股数。相对于当前股价 4400 日元，该公司在撰写时似乎接近公允价值。任何计算中的假设对估值有很大影响，因此最好将其视为粗略估计，而不是精确到最后一分钱。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/881041-dcf-1-dark-2/1753846130099" alt="" original-src="https://images.simplywall.st/asset/chart/881041-dcf-1-dark-2/1753846130099"/></p>
<p>TSE:9719 Discounted Cash Flow July 30th 2025</p>
<div class="lb-trans"><p>TSE:9719 折现现金流 2025 年 7 月 30 日</p>
</div><h2>Important Assumptions</h2>
<div class="lb-trans"><h2>重要假设</h2>
</div><p>We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at SCSK as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.5%, which is based on a levered beta of 1.338. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.</p>
<div class="lb-trans"><p>我们要指出，折现现金流中最重要的输入是折现率和实际现金流。你不必同意这些输入，我建议你自己重新计算并进行调整。DCF 也没有考虑行业的周期性或公司的未来资本需求，因此无法全面反映公司的潜在表现。鉴于我们将 SCSK 视为潜在股东，折现率使用股本成本，而不是资本成本（或加权平均资本成本，WACC），后者考虑了债务。在此计算中，我们使用了 7.5%，这是基于 1.338 的杠杆贝塔。贝塔是衡量股票相对于整个市场波动性的指标。我们从全球可比公司的行业平均贝塔中获得我们的贝塔，并设定在 0.8 到 2.0 之间，这是一个适合稳定企业的合理范围。</p>
</div><p>Check out our latest analysis for SCSK</p>
<div class="lb-trans"><p>查看我们对 SCSK 的最新分析</p>
</div><h3>SWOT Analysis for SCSK</h3>
<div class="lb-trans"><h3>SCSK 的 SWOT 分析</h3>
</div><p><strong>Strength</strong></p>
<div class="lb-trans"><p><strong>优势</strong></p>
</div><ul>
<li>Earnings growth over the past year exceeded its 5-year average.</li>
</ul>
<div class="lb-trans"><ul>
<li>过去一年的盈利增长超过了其 5 年平均水平。</li>
</ul>
</div><ul>
<li>Debt is well covered by earnings and cashflows.</li>
</ul>
<div class="lb-trans"><ul>
<li>债务由盈利和现金流良好覆盖。</li>
</ul>
</div><ul>
<li>Dividends are covered by earnings and cash flows.</li>
</ul>
<div class="lb-trans"><ul>
<li>股息由盈利和现金流覆盖。</li>
</ul>
</div><p>Dividend information for 9719.</p>
<div class="lb-trans"><p>9719 的股息信息。</p>
</div><p><strong>Weakness</strong></p>
<div class="lb-trans"><p><strong>劣势</strong></p>
</div><ul>
<li>Earnings growth over the past year underperformed the IT industry.</li>
</ul>
<div class="lb-trans"><ul>
<li>过去一年的盈利增长低于 IT 行业。</li>
</ul>
</div><ul>
<li>Dividend is low compared to the top 25% of dividend payers in the IT market.</li>
</ul>
<div class="lb-trans"><ul>
<li>与 IT 市场前 25% 的股息支付者相比，股息较低。</li>
</ul>
</div><p><strong>Opportunity</strong></p>
<div class="lb-trans"><p><strong>机会</strong></p>
</div><ul>
<li>Annual earnings are forecast to grow faster than the Japanese market.</li>
</ul>
<div class="lb-trans"><ul>
<li>年度盈利预计将比日本市场增长更快。</li>
</ul>
</div><ul>
<li>Good value based on P/E ratio compared to estimated Fair P/E ratio.</li>
</ul>
<div class="lb-trans"><ul>
<li>基于市盈率的估值相对公允市盈率而言具有良好价值。</li>
</ul>
</div><p><strong>Threat</strong></p>
<div class="lb-trans"><p><strong>威胁</strong></p>
</div><ul>
<li>Revenue is forecast to grow slower than 20% per year.</li>
</ul>
<div class="lb-trans"><ul>
<li>收入预计每年增长低于 20%。</li>
</ul>
</div><p>What else are analysts forecasting for 9719?</p>
<div class="lb-trans"><p>分析师对 9719 还有什么其他预测？</p>
</div><h2>Looking Ahead:</h2>
<div class="lb-trans"><h2>展望未来：</h2>
</div><p>Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For SCSK, there are three further items you should explore:</p>
<div class="lb-trans"><p>估值只是构建投资论点的一个方面，它只是你需要评估公司的众多因素之一。使用折现现金流（DCF）模型无法获得万无一失的估值。最好是应用不同的情景和假设，看看它们如何影响公司的估值。例如，如果终值增长率稍作调整，整体结果可能会发生显著变化。对于 SCSK，还有三个进一步的事项你应该探索：</p>
</div><ol>
<li><strong>Risks</strong>: For instance, we've identified <strong>1 warning sign for SCSK</strong> that you should be aware of.</li>
<li><strong>Future Earnings</strong>: How does 9719's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.</li>
<li><strong>Other High Quality Alternatives</strong>: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!</li>
</ol>
<div class="lb-trans"><ol>
<li><strong>风险</strong>：例如，我们已经识别出 <strong>SCSK 的一个警示信号</strong>，你应该注意。</li>
<li><strong>未来收益</strong>：9719 的增长率与其同行和更广泛市场相比如何？通过与我们的免费分析师增长预期图表互动，深入挖掘未来几年的分析师共识数字。</li>
<li><strong>其他高质量替代品</strong>：你喜欢全能型股票吗？探索我们互动式的高质量股票列表，了解你可能错过的其他投资机会！</li>
</ol>
</div><p>PS. Simply Wall St updates its DCF calculation for every Japanese stock every day, so if you want to find the intrinsic value of any other stock just search here.</p>
<div class="lb-trans"><p>PS. Simply Wall St 每天都会更新每只日本股票的 DCF 计算，因此如果你想找到其他股票的内在价值，只需在这里搜索。</p>
</div>

估算 SCSK 公司（TSE:9719）的合理价值